Inato Announces the Participation of Over 300 Clinical Trial Research Sites in its Global Marketplace

NEXT STORY
InveniAI and PRISM BioLab Initiate a Collaboration for the Development of Therapeutic Candidates for Treatment of Gut-Related Diseases Impacted by the Gut-Brain Axis and Inflammasome Activation Pathways
PREV STORY
Pfizer and BioNTech Announce Data From Preclinical Studies of mRNA-Based Vaccine Candidate Against COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cytori Reports Q2 2018 Business and Financial Results

SAN DIEGO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” or ...

author_avatar
NASDAQ Market News

Ohr Pharmaceutical Announces Fiscal Third Quarter 2017 Earnings

NEW YORK, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage ...

author_avatar
NASDAQ Market News

Tyme Technologies Announces Launch of a Pancreatic Research Program with the Mayo Clinic Led by Dr. Martin Fernandez-Zapico

NEW YORK, Dec. 13, 2016 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (“Tyme” or “the ...

author_avatar
NASDAQ Market News